Institutions / SilverArc Capital Management, LLC / Holdings
Back to SilverArc Capital Management, LLC

SilverArc Capital Management, LLC

All holdings · as of Dec 31, 2025

64 positions

CompanyClassValue ↓Shares% of portfolio
ABIVAX SA—$56.93M422,1938.2%
Cogent Biosciences, Inc.—$44.23M1,245,2546.4%
UROGEN PHARMA LTD—$40.72M1,738,8215.9%
KalVista Pharmaceuticals Inc—$39.20M2,427,1185.7%
Celcuity Inc.CELCCommon Stock$37.42M375,1325.4%
Nuvalent, Inc.—$31.33M311,4304.5%
Dianthus Therapeutics, Inc.—$30.91M750,1364.5%
Kodiak Sciences Inc.KODCommon Stock$28.61M1,023,1224.1%
Praxis Precision Medicines, Inc.—$24.31M82,4653.5%
Immunome Inc.—$24.19M1,126,2103.5%
FRACTYL HEALTH, INC.GUTSCommon Stock$21.65M9,840,0413.1%
Monte Rosa Therapeutics, Inc.—$16.14M1,029,0662.3%
VERACYTE INC—$15.05M357,5582.2%
CG Oncology, Inc.—$15.00M361,1582.2%
RHYTHM PHARMACEUTICALS, INC.—$14.55M135,9502.1%
Syndax Pharmaceuticals Inc—$13.51M642,8992.0%
BIOGEN INC.—$13.27M75,4121.9%
INSMED INC—$12.40M71,2561.8%
CENTESSA PHARMACEUTICALS PLC—$11.46M458,2031.7%
Viridian Therapeutics, Inc.—$10.85M348,5691.6%
ASCENDIS PHARMA A/S—$10.50M49,2281.5%
PFIZER INC—$10.44M419,1341.5%
Benitec Biopharma Inc.BNTCCommon Stock$9.86M731,7171.4%
Avalo Therapeutics, Inc.—$9.52M524,4361.4%
Guardant Health, Inc.—$9.39M91,9141.4%
Oric Pharmaceuticals, Inc.—$9.13M1,116,6041.3%
VAXCYTE, INC.—$6.87M148,7871.0%
Trevi Therapeutics, Inc.—$6.78M541,2401.0%
Gossamer Bio, Inc.—$6.62M2,135,7221.0%
SPYRE THERAPEUTICS, INC.—$6.15M187,7370.9%
Lexeo Therapeutics, Inc.—$6.13M617,6080.9%
Amylyx Pharmaceuticals, Inc.—$6.12M506,2420.9%
CERUS CORP—$5.80M2,814,3830.8%
Compass Therapeutics, Inc.—$5.65M1,051,3430.8%
SOLENO THERAPEUTICS, INC.—$5.44M117,4850.8%
COMPUGEN LTD—$5.32M3,479,8050.8%
Celldex Therapeutics, Inc.—$5.19M191,0740.8%
Olema Pharmaceuticals, Inc.—$5.16M206,2800.7%
Erasca, Inc.ERASCommon Stock$4.90M1,317,5840.7%
Fulcrum Therapeutics, Inc.—$4.46M394,6500.6%
Aardvark Therapeutics, Inc.AARDCommon Stock$3.99M303,9390.6%
C4 Therapeutics, Inc.CCCCCommon Stock$3.81M1,994,2240.6%
Surrozen, Inc./DESRZNCommon Stock$3.56M157,3230.5%
Contineum Therapeutics, Inc.—$3.52M307,5400.5%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$3.45M94,9830.5%
Relay Therapeutics, Inc.—$3.37M398,1670.5%
ABEONA THERAPEUTICS INC.—$3.31M627,7380.5%
TELA Bio, Inc.—$3.12M2,647,5120.5%
UNIQURE NV—$3.02M126,0470.4%
TARSUS PHARMACEUTICALS, INC.—$2.96M36,1240.4%
← PrevPage 1 of 2Next →